Quotient
Quotient Limited Fiscal Q4 Revenues Up 2 Percent
The firm had no revenues from its MosaiQ products, although it said that it has secured $1.4 million in orders for fiscal Q1 2023.
Quotient, Theradiag Announce Dx Partnership
Quotient said that it intends to develop a microarray-based test for connective tissue diseases with Theradiag.
Â
In Brief This Week: BioMérieux, LumiraDx, Chembio Diagnostics, Quanterix, Quest Diagnostics, More
News items for the in vitro diagnostics industry for the week of May 16, 2022.
In Brief This Week: Siemens Healthineers, Cue Health, Hologic, Theradiag, Quotient, and More
News items for the in vitro diagnostics industry for the week of March 21, 2022.
Quotient Limited Nabs CE Mark for Immunohematology Microarray
The microarray offers antibody screening and antigen typing on the firm's fully automated MosaiQ platform.
Jul 9, 2021